2 Biotech Stocks to Buy Hand Over Fist in April
These drugmakers have made important moves over the past year.
Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling?
The threat is still emerging, but it could be significant.
Got $1,000? Buy These Hot Growth Stocks Before They Take Off.
These stocks haven't been able to get much traction lately, even though they clearly deserve to now.
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst
The upcoming regulatory decision on its latest drug could be big.
Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript
SRPT earnings call for the period ending December 31, 2023.
Sarepta Therapeutics: Q4 Earnings Snapshot
Sarepta Therapeutics: Q4 Earnings Snapshot
Is It Too Late to Buy Sarepta Therapeutics Stock?
The company's hyperfocus on its core area could continue to be highly lucrative.
Why Sarepta Therapeutics Stock Is Soaring Today
The biotech just scored a big FDA win with an even bigger one potentially coming by June.
2 Magnificent Growth Stocks to Buy With $500
No need to break the bank to invest in promising stocks.
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
Bad news for one player does not always equal good news for another.